G&E Herbal Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 09, 2020 at 03:05 pm EDT
Share
G&E Herbal Biotechnology Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 5.121 million compared to TWD 5.433 million a year ago. Operating loss was TWD 5.601 million compared to TWD 6.579 million a year ago. Net loss was TWD 5.109 million compared to TWD 6.132 million a year ago. Basic loss per share was TWD 0.09 compared to TWD 0.11 a year ago. For the half year, sales was TWD 9.147 million compared to TWD 7.538 million a year ago. Operating loss was TWD 9.498 million compared to TWD 14.913 million a year ago. Net loss was TWD 9.043 million compared to TWD 14.223 million a year ago. Basic loss per share was TWD 0.16 compared to TWD 0.26 a year ago.
G&E Herbal Biotechnology Co., Ltd is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of health care food products, functional skin care products and pharmaceutical products. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The Company also provides botanical medicines for cancers and liver diseases. The Company distributes its products within domestic market and to overseas markets.
G&E HERBAL BIOTECHNOLOGY CO., LTD. 
